Filing Details
- Accession Number:
- 0000899243-23-008695
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-16 06:05:07
- Reporting Period:
- 2023-03-13
- Accepted Time:
- 2023-03-16 06:05:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1060736 | Seagen Inc. | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1206199 | G Daniel Welch | 21823 30Th Drive Se Bothell WA 98021 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-03-13 | 5,758 | $38.82 | 15,407 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2023-03-13 | 283 | $39.94 | 15,690 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-03-13 | 283 | $202.36 | 15,407 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2023-03-13 | 1,348 | $39.94 | 16,755 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-03-13 | 1,348 | $201.53 | 15,407 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2023-03-13 | 7,629 | $39.94 | 23,036 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-03-13 | 7,629 | $200.30 | 15,407 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-03-13 | 2,098 | $200.20 | 13,309 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-03-13 | 214 | $201.53 | 13,095 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-03-13 | 44 | $202.35 | 13,051 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-03-14 | 74 | $200.00 | 12,977 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2023-03-14 | 470 | $38.82 | 13,447 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-03-14 | 470 | $200.00 | 12,977 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-03-13 | 5,758 | $200.06 | 7,219 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-03-13 | 8,210 | $200.20 | 25,575 | No | 4 | S | Indirect | by Trust |
Common Stock | Disposition | 2023-03-13 | 808 | $201.53 | 24,767 | No | 4 | S | Indirect | by Trust |
Common Stock | Disposition | 2023-03-13 | 173 | $202.36 | 24,594 | No | 4 | S | Indirect | by Trust |
Common Stock | Disposition | 2023-03-14 | 288 | $200.00 | 24,306 | No | 4 | S | Indirect | by Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Indirect | by Trust |
No | 4 | S | Indirect | by Trust |
No | 4 | S | Indirect | by Trust |
No | 4 | S | Indirect | by Trust |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-03-13 | 5,758 | $0.00 | 5,758 | $38.82 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-03-14 | 470 | $0.00 | 470 | $38.82 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-03-13 | 283 | $0.00 | 283 | $39.94 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-03-13 | 1,348 | $0.00 | 1,348 | $39.94 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-03-13 | 7,629 | $0.00 | 7,629 | $39.94 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
3,502 | 2026-05-19 | No | 4 | M | Direct | |
3,032 | 2026-05-19 | No | 4 | M | Direct | |
8,977 | 2025-05-14 | No | 4 | M | Direct | |
7,629 | 2025-05-14 | No | 4 | M | Direct | |
0 | 2025-05-14 | No | 4 | M | Direct |
Footnotes
- Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $202.12 to $202.47. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $201.05 to $202.04. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $200.00 to $200.94. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $200.00 to $200.94. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $201.05 to $202.04. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $202.12 to $202.47. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $200.00 to $200.31. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Options were fully vested on 5/19/17.
- Options were fully vested on 5/14/16.